Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold
- PMID: 38698747
- DOI: 10.2174/0115680266308561240427065854
Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold
Abstract
Background: Human rhinovirus 3C protease (HRV-3Cpro) plays a crucial role in viral proliferation, establishing it as a prime target for antiviral therapy. However, research on identifying HRV-3Cpro inhibitors is still limited.
Objective: This study had two primary objectives: first, to validate the efficacy of an end-point colorimetric assay, previously developed by our team, for identifying potential inhibitors of HRV-3Cpro; and second, to discover phytochemicals in medicinal plants that inhibit the enzyme's activity.
Methods: Rupintrivir, a well-known inhibitor of HRV-3Cpro, was used to validate the colorimetric assay. Following this, we conducted a two-step in silico screening of 2532 phytochemicals, which led to the identification of eight active compounds: apigenin, carnosol, chlorogenic acid, kaempferol, luteolin, quercetin, rosmarinic acid, and rutin. We subsequently evaluated these candidates in vitro. To further investigate the inhibitory potential of the most promising candidates, namely, carnosol and rosmarinic acid, molecular docking studies were performed to analyze their binding interactions with HRV-3Cpro.
Results: The colorimetric assay we previously developed is effective in identifying compounds that selectively inhibit HRV-3Cpro. Carnosol and rosmarinic acid emerged as potent inhibitors, inhibiting HRV-3Cpro activity in vitro by over 55%. Our analysis indicated that carnosol and rosmarinic acid exert their inhibitory effects through a competitive mechanism. Molecular docking confirmed their competitive binding to the enzyme's active site.
Conclusion: Carnosol and rosmarinic acid warrant additional investigation for their potential in the development of common cold treatment. By highlighting these compounds as effective HRV-3Cpro inhibitors, our study presents a promising approach for discovering phytochemical inhibitors against proteases from similar pathogens.
Keywords: 3C protease; Colorimetric assay.; Common cold; Inhibition; Molecular docking; Phytochemicals.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.Bioorg Med Chem Lett. 2009 Jul 1;19(13):3632-6. doi: 10.1016/j.bmcl.2009.04.114. Epub 2009 May 3. Bioorg Med Chem Lett. 2009. PMID: 19464175 Free PMC article.
-
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.Antimicrob Agents Chemother. 2005 Feb;49(2):619-26. doi: 10.1128/AAC.49.2.619-626.2005. Antimicrob Agents Chemother. 2005. PMID: 15673742 Free PMC article.
-
Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.Bioorg Med Chem Lett. 2018 Aug 1;28(14):2533-2538. doi: 10.1016/j.bmcl.2018.05.046. Epub 2018 May 29. Bioorg Med Chem Lett. 2018. PMID: 29866517
-
Human rhinovirus 3C protease as a potential target for the development of antiviral agents.Curr Protein Pept Sci. 2007 Feb;8(1):19-27. doi: 10.2174/138920307779941523. Curr Protein Pept Sci. 2007. PMID: 17305557 Review.
-
Proteases of human rhinovirus: role in infection.Methods Mol Biol. 2015;1221:129-41. doi: 10.1007/978-1-4939-1571-2_10. Methods Mol Biol. 2015. PMID: 25261311 Review.
Cited by
-
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management.Int J Mol Sci. 2024 Jul 25;25(15):8105. doi: 10.3390/ijms25158105. Int J Mol Sci. 2024. PMID: 39125676 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical